Annual reports in medicinal chemistry

• 

  Año 2019, Número 52

  • Chapter One - Tuberculosis

    Steven J. Berthel, Christopher B. Cooper, Nader Fotouhi

    • Resumen

    págs. 1-25

    

  • Chapter Two - Antituberculosis agents: Beyond medicinal chemistry rules

    Marco Pierini

    • Resumen

    págs. 27-69

    

  • Chapter Three - Development of MmpL3 inhibitors for tuberculosis treatment

    Giovanna Poce, Sara Consalvi, Giulia Venditti, Cristina Scarpecci, Mariangela Biava

    • Resumen

    págs. 71-96

    

  • Chapter Four - Inhibitors of enzymes in the electron transport chain of Mycobacterium tuberculosis

    Andrew M. Thompson, William A. Denny

    • Resumen

    págs. 97-130

    

  • Chapter Five - Recent advances in the design of inhibitors of mycobacterial transcriptional regulators to boost thioamides anti-tubercular activity and circumvent acquired-resistance

    Nicolas Willand, Marion Flipo, Baptiste Villemagne, Alain Baulard, Benoit Deprez

    • Resumen

    págs. 131-152

    

  • Chapter Six - Sustainable anti-trypanosomatid drugs: An aspirational goal for medicinal chemistry

    María Laura Bolognesi

    • Resumen

    págs. 153-176